{"nct_id":"NCT02164006","title":"Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients","status":"COMPLETED","status_verified_date":"2019-10","start_date":"2014-06-11","start_date_type":"ACTUAL","primary_completion_date":"2016-05","primary_completion_date_type":"ACTUAL","completion_date":"2016-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TGTX"]}